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Canine babesiosis is caused by either 'large' or 'small' piroplasms. The latter, primarily *Babesia gibsoni*, are not of major concern in southern Africa and are not further considered here (Matjila *et al*. [@CIT0020]). Differences in clinical manifestation, immunology and vector specificity of isolates of 'large' babesias from various geographic regions were reported at an early stage (e.g. Brumpt [@CIT0003]; Christophers [@CIT0004]; Laveran & Nattan-Larrier [@CIT0016]; Robertson [@CIT0027]), but were mostly overlooked, and the organism was generally referred to as *Babesia canis* sensu lato. The situation changed when three groups of *B. canis* s. l. were distinguished and a new nomenclature was proposed (Uilenberg *et al*. [@CIT0032]). The 'large' piroplasms are a complex of at least three morphologically similar but genetically distinct vector-specific species: *B. canis*, *Babesia rossi* and *Babesia vogeli* (Zahler *et al*. [@CIT0034]). The pre-1989 literature on canine babesiosis should therefore be critically evaluated to determine which specific taxon is involved.

*Babesia rossi*, transmitted by *Haemaphysalis elliptica* and presumably also by *Haemaphysalis leachi* (Apanaskevich, Horak & Camicas [@CIT0002]), is restricted to sub-Saharan Africa and causes the most virulent manifestation of canine babesiosis. The less virulent *B. canis* sensu stricto, transmitted by *Dermacentor reticulatus*, is restricted to Europe (Brumpt [@CIT0003]). The least virulent species, *B. vogeli*, is transmitted by *Rhipicephalus sanguineus* sensu lato, which has a global distribution, but is most prevalent in tropical and subtropical regions (Gray *et al*. [@CIT0009]).

Canine babesiosis is regarded as a major problem in South Africa, where it has been well studied (Jacobson [@CIT0012]; Schoeman [@CIT0030]). The vast majority of cases are caused by *B. rossi*: at the Onderstepoort Veterinary Academic Hospital (OVAH), only 5 of 350 cases (1.4%) were attributed to *B. vogeli*, the remaining 98.6% of the patients being positive for *B. rossi* (Matjila *et al*. [@CIT0018]). At the OVAH, *H. elliptica* (reported as *H. leachi*) was collected from 304 of 395 dogs (77.0%) diagnosed with canine babesiosis, while *R. sanguineus* was collected from 146 (37%) of these dogs (Horak [@CIT0011]).

Initial reports indicated that canine babesiosis is not common in Namibia (Schneider [@CIT0029]). In a more recent study, Stübe ([@CIT0031]) identified *Babesia* piroplasms in 27 of 600 blood smears (4.5%) made from dogs in the Okahandja District of central Namibia. Using an enzyme-linked immunosorbent assay (ELISA) with *B.* *canis* antigen, 69% of the 600 dogs were found to be seropositive (Stübe [@CIT0031]). This test is known to cross-react with antibodies to *B. vogeli*, while the IFA test using this antigen cross-reacts with both *B. rossi* and *B. vogeli* (Dyachenko *et al*. [@CIT0007]; Jongejan *et al*. [@CIT0013]; Pantchev *et al*. [@CIT0026]). This would suggest either (1) an endemically stable situation, such as typically occurring with bovine babesiosis, or (2) the presence of a parasite of relatively low virulence.

Although we found no published reference to the occurrence of ticks on dogs in Windhoek, *R. sanguineus* s. l. was the most numerous tick species infesting dogs in Okahandja, Gobabis, Mariental and Rosh Pinah, Namibia (Matthee *et al*. [@CIT0021]; Stübe [@CIT0031]). All 796 ticks collected from dogs at Okahandja were *R. sanguineus* (Stübe [@CIT0031]); 99.2% of the ticks collected at the other three localities were also of this species (Matthee *et al*. [@CIT0021]). Among 899 ticks collected from dogs, Matthee *et al*. ([@CIT0021]) identified a single male of the genus *Haemaphysalis*; the species could not be determined. *Haemaphysalis elliptica* (reported as *H. leachi*), usually associated with more mesic conditions, has been reported from northern Namibia and once from Karasburg, southern Namibia (Walker [@CIT0033]).

On the basis of the abundance of *R. sanguineus* s. l., Noden and Soni ([@CIT0024]) ascribed clinical canine babesiosis cases in Namibia to *B. vogeli*. We can confirm that *B. vogeli* occurs in Namibia.

In February 2015, a dog presented at Windhoek Animal Hospital showed typical clinical signs of babesiosis. A blood smear was made, and large babesias were seen ([Figure 1](#F0001){ref-type="fig"}). The dog received the usual treatment and made an uneventful recovery. A stained blood smear was sent to the Department of Veterinary Tropical Diseases (DVTD) for confirmation of the diagnosis.

![A single *Babesia vogeli* trophozoite and two pairs of merozoites on a blood smear made at Windhoek Animal Hospital from a dog presented with clinical signs of babesiosis.](JSAVA-87-1427-g001){#F0001}

At the DVTD, the dried blood was removed from the slide. DNA was extracted using the QIAamp^®^ DNA Mini Kit (QIAGEN, Whitehead Scientific, South Africa) and subjected to the reverse line blot (RLB) hybridisation assay. A 460 bp -- 520 bp fragment of the V4 variable region of the parasite 18S rRNA gene was amplified by polymerase chain reaction (PCR) using the *Theileria* and *Babesia* genus--specific primers RLB F2 \[5'-GAC ACA GGG AGG TAG TGA CAA G-3'\] and biotin-labelled RLB R2 \[5'-Biotin-CTA AGA ATT TCA CCT CTA ACA GT-3'\] (Nijhof *et al*. [@CIT0022], [@CIT0023]). The PCR products were analysed using the RLB hybridisation assay, first described by Gubbels *et al*. ([@CIT0010]). The RLB membrane contained *Theileria* and *Babesia* genus-- and species--specific probes, including *B. canis* (5'-TGC GTT GAC GGT TTG AC-3'), *B. rossi* (5'-CGG TTT GTT GCC TTT GTG-3') and *B. vogeli* (5'-AGC GTG TTC GAG TTT GCC-3') (Matjila *et al*. [@CIT0019]).

On RLB, the PCR amplicons hybridised only with the *B. vogeli*--specific probe. Although attempts at cloning and sequencing of the full-length 18S rRNA gene were unsuccessful, we can confirm that *B. vogeli* occurs in central Namibia. This does not rule out possible occurrence of *B. rossi*, especially in the more mesic north-eastern parts of Namibia, including the Zambezi (previously Caprivi) region, where *H. elliptica* could occur since it is found in the adjoining Okavango region of Botswana (Walker [@CIT0033]).

In sub-Saharan Africa, *B. vogeli* was first reported from clinically normal dogs in South Africa (Matjila *et al*. [@CIT0019]). Its presence had probably been overlooked because of the preponderance of infections of the highly virulent *B. rossi* (Matjila *et al*. [@CIT0018]). *Babesia vogeli* has also been reported from Sudan (Oyamada *et al*. [@CIT0025]), Nigeria (Adamu *et al*. [@CIT0001]; Kamani *et al*. [@CIT0014]; Sasaki *et al*. [@CIT0028]) and Cape Verde (Götsch *et al*. [@CIT0008]). In Zimbabwe, *B. vogeli* has been reported from captive lions (*Panthera leo*), wild cats (*Felis lybica*) and servals (*Leptailurus serval*) and could presumably also occur in dogs (Kelly *et al*. [@CIT0015]).

*Rhipicephalus sanguineus* s. l., the only known vector of *B. vogeli*, is now thought to be a species-complex comprising at least 17 sibling species, which may differ in vector capacity (Dantas-Torres *et al*. [@CIT0005]; Dantas-Torres & Otranto [@CIT0006]). Domestication of the dog benefitted this tick, which probably evolved as a parasite of burrowing carnivores in warm climates (Gray *et al*. [@CIT0009]). Because of the worldwide spread of humans and dogs, this tick now has a global distribution. *Rhipicephalus sanguineus* s. l. is incriminated as vector of *Hepatozoon canis* and *Ehrlichia canis* in addition to *B. vogeli*. These pathogens could therefore be expected to occur throughout the geographic distribution of the vector (Gray *et al*. [@CIT0009]). Indeed, 53.8% of 106 dogs from Windhoek, Namibia, were seropositive on a solid-phase dot ELISA based on a crude antigen of *E. canis* (Israeli strain) (Manyarara *et al*. [@CIT0017]).
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